EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Peptidyl tRNA Hydrolase Is Required for Robust Prolyl-tRNA Turnover in Mycobacterium tuberculosis

Francesca G Tomasi iD, Jessica T P Schweber, Satoshi Kimura, Junhao Zhu, Laura A T Cleghorn, Susan H Davis, Simon R Green, Matthew K Waldor, Eric J Rubin iD

mBio · 2023

DOI: 10.1128/mbio.03469-22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, 2023. Verfasst von Francesca G Tomasi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Amino Acyl-tRNA Synthetases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID), U.S. Department of Defense.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peptidyl tRNA hydrolase (Pth) is an enzyme that cuts unfinished peptides off tRNA that has been prematurely released from a stalled ribosome. Pth is essential in nearly all bacteria, including the pathogen Mycobacterium tuberculosis (Mtb), but it has not been clear why.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisAmino Acyl-tRNA SynthetasesRNA, TransferPeptidesHydrolasesCarboxylic Ester Hydrolases

Stichwörter der Autor:innen

Mycobacterium tuberculosisantibiotic resistancebacterial geneticsribosomestRNAtRNA sequencingtranslation

Substanzen

RNA, TransferPeptidesAmino Acyl-tRNA SynthetasesHydrolasesCarboxylic Ester Hydrolases

Autor:innen und Institutionen

  • Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Department of Microbiology, Harvard Medical School, Boston, Massachusetts, USA.
  • Howard Hughes Medical Institute, Boston, Massachusetts, USA.
  • Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, College of Life Sciences, University of Dundee, Dundee, United Kingdom.

ORCID-Profile: Francesca G Tomasi, Eric J Rubin

Förderung

  • NIAID NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
  • U.S. Department of Defense

Zitieren

APA

Tomasi, F. G., Schweber, J. T. P., Kimura, S., Zhu, J., Cleghorn, L. A. T., Davis, S. H., Green, S. R., Waldor, M. K., & Rubin, E. J. (2023). Peptidyl tRNA Hydrolase Is Required for Robust Prolyl-tRNA Turnover in Mycobacterium tuberculosis. mBio. https://doi.org/10.1128/mbio.03469-22

Vancouver

Tomasi FG, Schweber JTP, Kimura S, Zhu J, Cleghorn LAT, Davis SH, et al. Peptidyl tRNA Hydrolase Is Required for Robust Prolyl-tRNA Turnover in Mycobacterium tuberculosis. mBio. 2023. doi:10.1128/mbio.03469-22

BibTeX
@article{Tomasi2023,
  author = {Tomasi, Francesca G and Schweber, Jessica T P and Kimura, Satoshi and Zhu, Junhao and Cleghorn, Laura A T and Davis, Susan H and Green, Simon R and Waldor, Matthew K and Rubin, Eric J},
  title = {Peptidyl tRNA Hydrolase Is Required for Robust Prolyl-tRNA Turnover in Mycobacterium tuberculosis},
  journal = {mBio},
  year = {2023},
  doi = {10.1128/mbio.03469-22}
}
Kostenlos starten →